(Q45778916)

16 December 2017

title

Hepatitis B virus infection in chronic uremia: long-term follow-up of a two-step integrated protocol of vaccination. (English)

1 reference

16 December 2017

1 reference

1 reference

Marangi AL

1

1 reference

16 December 2017

Giordano R

2

1 reference

16 December 2017

Montanaro A

3

1 reference

16 December 2017

De Padova F

4

1 reference

16 December 2017

Schiavone MG

5

1 reference

16 December 2017

Dongiovanni G

6

1 reference

16 December 2017

Basile C

7

1 reference

16 December 2017

publication date

1 April 1994

1 reference

16 December 2017

American Journal of Kidney Diseases

published in

1 reference

16 December 2017

volume

23

1 reference

16 December 2017

issue

4

1 reference

16 December 2017

page(s)

537-542

1 reference

16 December 2017

Controlled trial of thymopentin in hemodialysis patients who fail to respond to hepatitis B vaccination

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980375-1

7 January 2021

Low-dose interleukin-2 induces systemic immune responses against HBsAg in immunodeficient non-responders to hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980375-1

7 January 2021

Immune response to hepatitis B vaccine in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980375-1

7 January 2021

Complete Seroconversion by Low-Dose Intradermal Injection of Recombinant Hepatitis B Vaccine in Hemodialysis Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980375-1

7 January 2021

A successful two-step integrated protocol of anti-HBV vaccination in chronic uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980375-1

7 January 2021

Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980375-1

7 January 2021

Long-term evaluation of the hepatitis B vaccine (Heptavax-B) in hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980375-1

7 January 2021

Development of skin reaction to hepatitis B vaccines in man

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980375-1

7 January 2021

Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980375-1

7 January 2021

Intradermal hepatitis B virus vaccine: immunogenicity and side-effects in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980375-1

7 January 2021

Appraisal of intradermal immunisation against hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980375-1

7 January 2021

Genetic prediction of nonresponse to hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980375-1

7 January 2021

ENTRADERMAL HEPATITIS B VACCINE

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980375-1

7 January 2021

Evaluation of a reduced dose of hepatitis B vaccine administered intradermally

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980375-1

7 January 2021

Timing of hepatitis B revaccination in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980375-1

7 January 2021

Decline of anti-HBs after hepatitis B vaccination and timing of revaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980375-1

7 January 2021

10.1016/S0272-6386(12)80375-1

Identifiers

DOI

1 reference

16 December 2017

1 reference

16 December 2017